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Bowman–Birk inhibitor (BBI) is a protease inhibitor that aff ects protein digestibility; however, it is increasingly 
being recognised as anutraceutical and cosmeceutical molecule. In the present study, BBI concentration during 
soybean seed development, its loss during processing treatments, and the level in commercial soy products were 
determined. Signifi cant diff erences for BBI concentration were observed across the genotypes and seed development 
stages. Genotype × seed development stage interaction was also found to be signifi cant (P<0.05) for BBI 
concentration. Boiling, autoclaving, microwave irradiation, and sprouting resulted in signifi cant (P<0.05) loss of 
BBI. Minimum loss was observed in sprouting, while autoclaving for 5 min completely deactivated BBI. Microwave 
irradiation of the soaked seeds resulted in higher BBI loss than of dry seeds. Among the commercial soy products, 
BBI concentration was high in soy fl our brands, minuscule in ready-to-cook miso soup and undetectable in extruded 
soy products and roasted soy nuts.
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Being the potential contributor of protein in vegetarian/vegan diet, soy products are gaining 
the attention of consumers across the globe. Beside minerals, vitamins, omega-3 fatty acids, 
and fi bre, soybean is a rich source of biomolecules, namely isofl avones, tocopherols, and 
lecithin, which have been demonstrated to reduce the risk of onset of several killer diseases 
(K  et al., 2010; M , 2016). These active ingredients of nutraceutical importance 
are commercially available in several countries. One of the protease inhibitors present in 
soybean, namely Bowman–Birk inhibitor, a 8 kDa polypeptide comprising of 71 amino acids, 
which aff ects the digestibility of proteins, is even increasingly being recognised as an 
anticancer and cosmeceutical molecule. In 1992, the Food and Drug Administration gave 
soybean BBI concentrate (BBIC) the status of Investigational New Drug. A plethora of 
studies suggesting the anticancer activity of BBI in both in vitro and in vivo models are 
available (K , 2005; C  et al., 2010). This biomolecule was demonstrated for 
its effi  cacy against oral leukoplakia (A  et al., 2013), prostatic hyperplasia 
(M  et al., 2001), and colorectal cancer (C   A , 2014). BBI has also 
been reported to suppress multiple sclerosis and attenuate muscular atrophy (D  et al., 2011). 
Further, BBI in soybean is a potential cosmeceutical molecule, known for its role in skin 
health, weight loss, and prevention of hair loss (L , 2010; S  et al., 2012; K  et al., 
2017). Therefore, the retention of BBI during processing of soy products is desirable in 
contrast to Kunitz trypsin inhibitor (KTI), which aff ects protein digestibility and causes 
pancreatic hypertrophy in its active form and is sought to be completely inactivated in soy 
products.
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Several processing methods like heating, extrusion, sprouting, or combinations of these 
treatments are employed by soy food industry to inactivate KTI (D  et al., 2012; C  et al., 
2014). BBI has relatively better thermo-stability than KTI due to the presence of 5 more 
disulfi de linkages in its structure than KTI, however, these inactivation methods result in the 
collateral loss of BBI. Commercial soy food products undergo diff erent types of processing 
treatments during manufacturing, which may aff ect BBI concentration. However, the reports 
pertaining to genotypic variation and loss of BBI due to processing treatments are scarce 
(F  et al., 1991). K  and co-workers (2018) investigated BBI concentration in 7 
soybean varieties, which exhibited 3.2-fold variation for the trait. Further, in several countries, 
consumption of green soybean at immature stage, known as edamame, is becoming 
increasingly popular compared to soy products processed from mature grains. Better 
acceptability of edamame among masses is attributed to reduced off /beany fl avour and 
negligible fl atulence-inducing oligosaccharides content compared to soy products processed 
from mature soybean grains. Therefore, it is worthwhile to assess BBI concentration at 
diff erent soybean seed development stages to understand its level at the picking stage of 
edamame. Reports concerning the concentration of BBI even in the commercial soy products 
are limited (H -L  et al., 2009). In the present investigation, 2 soybean 
varieties of India were assessed for BBI concentration at diff erent reproductive stages to 
investigate the dynamics of BBI accumulation. Mature seeds of one variety were subjected 
to boiling, microwave, autoclaving, and sprouting to assess BBI loss due to these processing 
methods. In several countries, a wide array of soy-based products has appeared in market to 
meet consumer needs. Diff erent types of these commercially available soy products undergo 
diff erent processing methods or combination of them, which would impact BBI concentration 
diff erently. Besides, diff erent types of soy products, such as soy fl our, soy chunks, soy 
granules, ready-to-cook miso soup, roasted soy nuts, were also analysed for BBI concentration.
1. Materials and methods
1.1. Soy products
Soy fl our, soy chunks, soy granules, roasted soy nuts, and ready-to-cook miso soup were 
commercial products and purchased from the market.
1.2. Picking at diff erent growth stages
Three soybean genotypes, namely NRC127, DS228, and JS97-52, were raised in the fi eld in 
single row plot of 3 meter length with plant-to-plant and row-to-row distance of 5 and 45 cm, 
respectively, in triplicate in randomised block design. These 3 genotypes are soybean varieties 
released for cultivation in India. Green pods of 2 genotypes, namely NRC127 and DS228, 
were picked at R5, R6, and R7 stage as described by F  and co-workers (1971). Fresh 
tender seeds were shelled from these green pods and recorded for moisture content and 100 
green seed fresh weight. A fi xed weight of green seeds picked at each of the reproductive 
stages was taken for BBI estimation and the data were converted on dry weight basis.
1.3. Processing treatments
Seeds of soybean variety JS 97-52 were subjected to boiling, autoclaving, microwave 
irradiation, and sprouting. Dry seeds were boiled in distilled water at 100 °C for 5, 10, and 15 
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min. Autoclaving of soybean seeds was carried out at 121 °C and 15 psi for 15 min. For 
microwave treatment, both dry and pre-soaked seeds (immersed in distilled water for 30 min) 
were irradiated in microwave oven (Samsung Model-MC28H5015VB, 0.6 KW power set at 
2450 MHz frequency) for 1 and 2 min. For sprouting, soybean seeds were sprouted in 
germination paper at 28 °C, and the seedlings were drawn for analysis after every 24 h till 4 
days.
1.4. Extraction and estimation of BBI through ELISA
Defatted soy fl our (50 mg) was suspended in 1 ml of 50 mM Tris buff er (pH 8.2) and 
homogenised using Polytron homogeniser (Kinematica, Model PT2100, Switzerland) 
followed by ultra-sonication (PCI Analytics) for 1 h. The suspension was centrifuged at 
20 000 g for 35 min at 4 °C. The resultant supernatant was diluted 25 000 times using 
phosphate buff er saline. A standard curve (y=0.03x+0.3146, R2=0.996) was generated using 
varying BBI standard concentration. BBI concentration in samples was quantifi ed using 
indirect ELISA method as described elsewhere (K  et al. 2018).
1.5. Statistical analysis
All steps and assays were performed in triplicate with satisfactory repetition of values. Data 
presented in Table 1 and 2 are mean ± standard deviation of 3 independent replicates. All 
statistical analyses were carried out through SAS 9.3 with signifi cance at P˂0.05.
2. Results and discussion
2.1. Genotypic and seed development stages diff erences
In general, mature soybean seeds are used as raw material for processing diff erent soy 
products. However, soybean is picked at immature stage, i.e. R5, R6, or between R6-R7 
stages for consumption as vegetable. Figure 1 depicts BBI concentration in 2 soybean 
varieties picked at 3 seed development stages, namely R5, R6, and R7 stages of reproductive 
phase. These seed development stages, i.e. R5, R6, and R7 in soybean have been defi ned by 
F  and co-workers (1971). Fresh green seed weight of these 2 genotypes increased as 
reproductive stage transitioned from R5 to R6 and thereafter from R6 to R7 stage. BBI 
concentrations in mature seeds of NRC127 and DS228 were found to be 11.4 and 3.7 mg g–1 
dry matter, respectively, exhibiting about 4 fold genotypic variation. Further, it may be noted 
that NRC127 is a KTI free soybean variety released for cultivation in India, and is essentially 
derived from variety JS97-52, as the former constitutes 96.2% genome of the latter (AICRPS, 
2018). BBI concentration in NRC127 continuously increased as the seed development 
progressed from R5 to R8 stage. At R5 stage, BBI concentration in NRC127 was 4.83 mg g–1 
dry matter, which spiked to 11.4 mg g–1 dry matter at maturity. The variety registered 
maximum increase of 52.0% in BBI accumulation between R5 to R6 stages, 21.4% increase 
between R6 and R7 stages and 27.9% increase between R7 and R8 stages. In case of DS228, 
at R5 stage, BBI concentration was 1.89 mg g–1 dry matter, which at R8 stage increased to 3.7 
mg g–1 dry matter. Like NRC127, DS228 registered about 52% increase in BBI between R5 
and R6 stages, however, both between R6 and R7, and R7 and R8 stages, the percent increase 
in BBI concentration was about half of NRC127. These results showed that the eff ects of 
genotype, seed development stage, and genotype × seed development stage interaction were 
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signifi cant (P<0.05) on the accumulation of BBI concentration in soybean. The data showed 
that soybean at R5 stage may possess half the concentration of BBI at full maturity. To 
compare our results, we could not come across any previous studies wherein accumulation 































Fig. 1. BBI concentration of soybean genotypes DS228 and NRC127 at diff erent seed development stages (R5, 
R6, R7, and R8). Numerical value given on the top of the bar corresponds to BBI concentration mg g–1 dry matter 
at the particular seed development stage of genotype
: R5; : R6; : R7; : R6
2.2. Eff ect of processing treatments
Variety JS97-52 was chosen for investigating the eff ect of processing treatment. BBI 
concentration in the untreated sample of JS97-52 (7.4 mg g–1) was also found to be much 
lower than observed in NRC127 (11.4 mg g–1). The data pertaining to the loss of BBI due to 
4 processing treatments, i.e. boiling, autoclaving, microwave irradiation, and sprouting, are 
presented in Table 1. Boiling of seeds for 5, 10, and 15 min reduced BBI from 7.4 to 3.4, 1.5, 
and 1.2 mg g–1, thereby causing 52, 79.7, and 83.8% loss, respectively. The results of our 
previous study (K  et al., 2019) showed that boiling of soybean seeds for 5 and 10 min 
caused a loss of KTI, the major protease inhibitor in soybean, to the magnitude of 68.8 (from 
11.2 to 3.5 mg g–1) and 75.9% (from 11.2 to 2.7 mg g–1), respectively. Autoclaving (at 121°C 
and 15 psi) of soybean seeds for 15 min completely deactivated BBI. Complete inactivation 
of KTI as a result of autoclaving for 15 min has also been reported in our previous study 
(K  et al., 2019). F  and co-workers (1991) investigated the eff ect of autoclaving 
of soy fl our on BBI content, and reported 78.0 and 98.8% loss of BBI in soy fl our on 
autoclaving at 121°C for 10 and 20 min, respectively, which is comparable to the extent of 
BBI loss due to autoclaving for 15 min in the present study.
With regard to microwave irradiation, this treatment for 1 min in dry seeds plummeted 
BBI from 7.4 to 5.4 mg g–1, causing 27% loss, however, exposure of soaked seed to microwave 
radiation for the same duration reduced this biomolecule concentration from 7.4 to 0.5 mg g–1, 
resulting in 93.4% loss, i.e. about 3-fold higher loss than in dry seeds. Higher percentage of 
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loss for BBI was registered in both dry and soaked seeds with 2 min exposure to microwave 
irradiation compared to the lesser duration of 1 min, i.e. microwave irradiation induced loss 
of BBI was proportionate to exposure time, whether the seeds were soaked or dried. Our 
results also showed that microwave irradiation for 2 min also caused signifi cantly higher BBI 
loss in soaked seeds than in dry seeds. Similar observations were reported for KTI reduction 
due to microwave irradiation in an earlier study (K  et al., 2019), which reported the 
reduction of the KTI due to microwave irradiation as a function of exposure time and the 
moisture percent in seed, and the higher reduction observed in soaked compared to dried 
seeds on microwave irradiation may be because of the higher electric dipole forms due to 
water molecules in the former case, which may result in intense heat energy transfer to 
proteins. In literature, the studies demonstrating the eff ect of microwave irradiation on total 
trypsin inhibitor activity (TIA) on soybean and other beans are available. S  and 
co-workers (2010) reported 15.0 and 26.84% reduction in TIA of dry Polish bean fl our on 
exposure to microwave irradiation for 1 and 2 min, respectively.
Table 1. Changes in BBI concentration in soybean due to diff erent processing treatments
Treatment BBI concentration 
mg g–1 dry matter
Percent reduction 
compared to the control
Control 7.4±0.37a
Boiling
5 min 3.4±0.19d 54.1
10 min 1.5±0.10e 79.7
15 min 1.2±0.10e 83.8
Autoclaving (15 min) n.d. 100
Microwave irradiation (dry seeds)
1 min 5.4±0.18c 27.0
2 min 1.2±0.09e 83.8
Microwave irradiation (pre-soaked seeds)
1 min 0.5±0.07f 93.2
2 min. 0.4±0.03f 94.6
Sprouting
1 day 7.6±0.48a 0
2 days 7.1±0.45a 4.1
3 days 6.6±0.41b 10.8
4 days 6.2±0.35b 16.2
Values given are means of triplicate ± standard deviation and expressed on dry weight basis. Values superscripted 
with diff erent letters are signifi cantly (P<0.05) diff erent from each other. n.d.: not detected
The data presented in Table 1 also show that sprouting caused only 10.8 and 16.2% loss 
in BBI concentration in soybean on 3rd and 4th day, which is comparable to 13% loss reported 
for this molecule after 3 days of sprouting in soybean in an earlier study (D  et al., 2012). 
BBI loss occurring after 4 days of sprouting was about one fi fth of the reduction (66.1%) for 
KTI concentration reported in our previous study (K  et al., 2019). D  and co-workers 
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(2012) investigated the eff ect of germination on BBI in soybean seeds sprouted for 72 h (3 
days) at 25 °C and reported non-signifi cant changes in both KTI and BBI due to sprouting. 
A 10.8% reduction in BBI after 72 h in our results may be attributed to higher temperature at 
which sprouting was carried out in the present investigation. The decline in BBI due to 
sprouting may be because of the de novo synthesis of proteases during sprouting as suggested 
in an earlier study (P   W , 1991).
2.3. Concentration in commercial products
Table 2 presents BBI concentration in diff erent types of soy products analysed. Soy fl our 
showed very high BBI concentration, which was as high as reported in soybean varieties 
(K  et al., 2018). This shows that no heat treatment has been applied during soy-fl our 
manufacturing of these brands. However, in the rest of the soy-products, such as soy granules, 
soy chunks, and roasted soy nuts, BBI concentration was non-detectable. Soy granules and 
soy chunks both are extruded products. C  and W  (2007) investigated the eff ect 
of extrusion conditions on TIA of full fat soybean, and reported negligible value of 1.6 mg g–1, 
which could be due to BBI only, as extrusion completely destroys KTI. BBI was not detectable 
in roasted soybean nuts either. B  and S  (2005) reported that 2 min of 
microwave roasting led to about 88% reduction of total TIA and the residual activity in this 
study may be attributed to BBI. In the present study, though both modes of roasting and the 
duration of roasting in roasted soy nuts packets were not mentioned, however, non-detectable 
values of BBI may be due to exhaustive roasting treatment given to this soy-product rather 
than microwave roasting applied for only 2 min in the above mentioned study. Further, 
minuscule BBI concentration observed in ready-to-cook soy miso soup may be because of 
the presence of benefi cial fungi culture in this product, which release proteases to degrade 
BBI.
Table 2. BBI concentration in diff erent soy products
Soy product BBI mg g–1 product dry weight basis
Soy fl our 12.4±0.21
Ready-to-cook miso soup 0.003
Soy granules n.d
Soy chunks n.d.
Roasted soy nuts n.d.
Values given are mean of triplicate ± standard deviation and expressed on dry weight basis. n.d corresponds to non-
detectable.
3. Conclusions
In the backdrop of recent reports demonstrating the nutraceutical value of BBI, the 
accumulation pattern of BBI during seed development as a function of genotype was 
investigated and the loss of BBI due to diff erent processing treatments was assessed. Most of 
the studies conducted so far concerning the eff ects of processing treatments focused on total 
TIA, which does not distinguish KTI from BBI. In the present study, eff ect of genotype, seed 
development stage, and genotype ×seed development stage interaction on BBI concentration 
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was found to be signifi cant (P<0.05). Among all the processing treatments employed in the 
study, sprouting caused minimum BBI loss. Among diff erent types of the commercial soy 
products investigated, extruded and roasted soy products were found to be devoid of BBI.
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